Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: Possible involvement of different binding sites at the PPARγ receptor
- García, C.
- Gómez-Cañas, M.
- Burgaz, S.
- Palomares, B.
- Gómez-Gálvez, Y.
- Palomo-Garo, C.
- Campo, S.
- Ferrer-Hernández, J.
- Pavicic, C.
- Navarrete, C.
- Luz Bellido, M.
- García-Arencibia, M.
- Ruth Pazos, M.
- Muñoz, E.
- Fernández-Ruiz, J.
Aldizkaria:
Journal of Neuroinflammation
ISSN: 1742-2094
Argitalpen urtea: 2018
Alea: 15
Zenbakia: 1
Mota: Artikulua
